Related Experiment Video
Updated: Aug 16, 2026

The WATCHMAN Left Atrial Appendage Closure Device for Atrial Fibrillation
Published on: February 28, 2012
Stroke prevention: what's new?
1Acute Stroke Unit, Department of Medicine, University of Melbourne and Clinical Neurosciences Department, St Vincent's Hospital, Melbourne, Victoria, Australia. rgerraty@medstv.unimelb.edu.au
Insights
New stroke prevention strategies include ACE inhibitors and statins, alongside antithrombotics. Advanced imaging and surgical interventions like carotid endarterectomy are crucial for secondary stroke prevention, with ongoing trials for other methods.
Area of Science:
- Neurology
- Cardiology
- Vascular Surgery
Background:
- Stroke prevention has evolved beyond antithrombotic therapy.
- New drug classes like ACE inhibitors and statins are now established interventions.
- Atrial fibrillation remains a key indication for anticoagulation, though efficacy in other groups is under investigation.
Purpose of the Study:
- To review current evidence-based strategies for stroke prevention.
- To highlight the role of advanced diagnostics and interventional procedures.
- To discuss emerging treatments and their supporting data.
Main Methods:
- Review of recent clinical trials and evidence-based guidelines.
- Analysis of diagnostic imaging techniques, specifically diffusion-weighted MRI.
- Evaluation of surgical and interventional procedures for cerebrovascular disease.
Main Results:
- Angiotensin-converting enzyme inhibitors and statins are effective secondary stroke prevention agents.
- Diffusion-weighted MRI enhances acute stroke diagnosis, guiding secondary prevention.
- Carotid endarterectomy is beneficial for symptomatic stenosis (50-69% and 70-99%), with angioplasty/stenting showing comparable procedural risks in limited data.
- Device closure for cardiac abnormalities lacks trial data, despite low stroke risk with aspirin in patent foramen ovale.
Conclusions:
- Stroke prevention requires a multi-faceted approach combining pharmacotherapy, advanced diagnostics, and revascularization procedures.
- Further research is needed for device closure efficacy and anticoagulation in non-atrial fibrillation stroke-prone groups.
- Personalized secondary prevention strategies are informed by accurate diagnosis and risk stratification.
Abstract:
Abstract Antithrombotic treatment has now been joined by other evidence-based drug interventions for prevention of stroke, including angiotensin-converting enzyme inhibitors and hydroxymethylglutaryl-CoA reductase inhibitors. The efficacy of oral anticoagulation in atrial fibrillation has not been seen in other stroke-prone groups, although trials are continuing. Diffusion-weighted magnetic resonance imaging improves diagnostic accuracy in acute stroke, which is important in arriving at the right secondary prevention strategy. Carotid endarterectomy has been shown to be beneficial for 50-69% symptomatic -stenosis but with a much narrower therapeutic index than for 70-99% stenosis. A comparison of endarterectomy with angioplasty and/or stent placement has been the subject of one small trial suggesting similar procedural stroke and mortality risks. Device closure of cardiac abnormalities increases in the absence of any trial data, and in spite of a low subsequent stroke risk for young patients with isolated patent foramen ovale treated with aspirin.
Related Concept Videos
Regulation of Stroke Volume
Preload refers to the degree of stretch on the heart before it contracts. It's analogous to the stretching of a rubber band; the more it's stretched, the more forcefully it snaps back. This concept is encapsulated in the Frank-Starling law of the...
Coronary Artery Disease IV: Preventive Measures
Venous Thrombosis III: Interprofessional Care
Ischemic Stroke l: Introduction
Hemorrhagic Stroke l: Introduction
Hemorrhagic Stroke ll: Pathophysiology

